About EpigenCare

Scientifically Grounded

How does a consumer know whether a skincare product is truly working for them? EpigenCare is connecting consumers with skincare companies through a direct-to-consumer skincare test and web platform on the Ethereum network. Consumers will be able to receive actionable recommendations of optimized skincare products to use, as well as assess the progress of their skincare routines, based on their skin’s epigenetic profiles. The recommendation engine looks at the functional state of a panel of epigenetic markers strongly correlated with skin quality indicators (e.g., aging, moisture retention, elasticity, etc.), and how skincare product ingredients affect them.

 

A Cyclical Growth Ecosystem

As epigenetics regulates gene function and dynamically changes based on environment stimuli such as skincare product ingredients, it is a perfect fit for a recurring, tokenized business model. EpigenCare’s upcoming platform will be a structured ecosystem that allows skincare companies to target data segments with products that fulfill the recommendation engine’s matching requirements. Consumers that fall within the segment are rewarded with tokens, which can be used to subsidize additional tests (thereby generating additional advertising inventory for companies).

 

Disrupting the Skincare Industry

Our structured ecosystem allows for true leveraging of blockchain technology. The recurring nature of epigenetics allows for a perpetual incentivization model through data tokenization. By associating a transaction hash ID with each purchased test and data segment, we will be able to transparently prove that a consumer’s data is used only for their own benefit, thereby addressing the problem of perceived intrusiveness often associated with commercialized DNA-related testing. EpigenCare’s disruptive innovation introduces a new marketing channel to the $130 billion skincare industry and transform the way companies market their products to consumers through scientifically screened, individualized advertising.

 

Features

Offered under SEC Regulation CF, S, and D exemptions.

Technical Info

EpigenCare tokenizes data generated from their personal epigenomics system in a controlled ecosystem such that data movement is recorded on the blockchain ledger. Consumers can verify that their data was used directly for their own benefit in the form of a personalized product recommendation, and not through any other means. This solves the problem of perceived intrusiveness often associated with direct-to-consumer tests requiring consumer DNA.

EpigenCare Roadmap

 
  • Q2, 2017

  • EpigenCare Inc. Established in New York, USA
  • Q4 2017

  • Epigenetic-based Skincare Test Successfully Developed and Proven
  • Q4 2017

  • Epigenetic-based Skincare Test Successfully Developed and Proven
  • Q1 2018

  • ICO Token Generation Event
  • Q1 2018

  • ICO Token Generation Event
  • Q2 2018

  • Launch Marketing Campaign for Product Pre-Orders
  • Q3 2018

  • Limited Launch of Beta Skincare Test
  • Q4 2018

  • Full Skincare Test Launch to Public; Launch EpigenCare Network Open Beta
  • Q1 2019

  • Launch Consumer Mobile Application
  • Q2 2019

  • Launch Official EpigenCare Network Platform
  • Q2 2019

  • Launch Official EpigenCare Network Platform
  • Q3 2019

  • Retail Distribution Initiative; Deploy API (Application Programming Interface)
  • Q4 2019

  • Dermatologist/Spa/Beauty Salon Partnership Initiative
  • Future Objectives

  • Integrate Deep-Learning Artificial Intelligence Elements Based on Epigenetic Skin Data; Develop Complementary A-I-Based Mobile Imaging Application
Read Less